Proxy Laboratories

Name

Proxy Laboratories

Legal name

Eurofins BioPharma Product Testing Netherlands

Website

https://proxylab.nl

Company type

Public

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical and Medical Device Laboratory Testing Services

NAICS

Testing Laboratories and Services (54138), Testing Laboratories and Services (541380), Medical and Diagnostic Laboratories (6215)

SIC

Services-Testing Laboratories (8734), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Release Testing & Batch Certification (QC) (HLAGADAC)

akta.pro secondary industries

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL)

Keywords

• Pharmaceutical laboratory testing
• Medical device testing
• GMP manufacturing services
• Biopharmaceutical release testing
• Method development validation

Headquarters

HQ city

Netherlands

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Contract-based laboratory testing services for (bio)pharmaceutical and medical device companies. Includes method development, validation, and regulatory compliant testing under GMP and GLP conditions.
2. GMP Manufacturing Services: Aseptic manufacturing, fill & finish, labelling and packaging services for pharmaceutical products
3. Consultancy Services: Technical consultancy services including method development from scratch or transfer of client methods under regulatory compliant conditions

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Proxy Laboratories (Eurofins BioPharma Product Testing Netherlands) delivers GMP-, GLP-, and ISO-accredited laboratory testing services, GMP-compliant small-scale aseptic manufacturing and fill & finish, and technical consultancy for (bio)pharmaceutical and medical device companies. Its portfolio covers testing of drug substances, final products, intermediates, and starting materials for small and large molecule drug products, plus manufacturing services including labelling and packaging. Customers include pharmaceutical and medical device companies in the Netherlands and broader Eurofins network, who access laboratory data in real time through the LabAccess Portal.

Product overview

Eurofins PROXY Laboratories is part of Eurofins BioPharma Product Testing Netherlands, operating as a network of harmonized product testing laboratories with over 20 years of experience serving the (bio)pharmaceutical and medical device industry. The portfolio consists of comprehensive laboratory, manufacturing, and consultancy services organized around six core testing domains: Small Molecules Testing, Biologics Testing, Medical Devices Testing, Biocides Testing, and GMP Manufacturing Services. These services are supported by specialized capabilities including Cell Banks, Facility and Process Control, Method Development and Validation, Release Testing (spanning biosafety, identity, quality control, and solid-state characterization), and Stability Testing. The company operates multiple aseptic manufacturing units for small-scale compounding and fill-and-finish activities, including labelling and packaging services. Customers access the platform via LabAccess Portal for real-time data. Services cover testing of drug substances, final products, intermediates, and starting materials for both small and large molecule drug products and medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Biocides Testing Services Comprehensive testing services for the biocidal industry including biopesticides testing and evaluation of detergents and household products for regulatory compliance.
• Cell Banks Cell banking services supporting the (bio)pharmaceutical industry with characterized and validated cell lines for biopharmaceutical manufacturing.
• Facility and Process Control Services Comprehensive facility validation services including cleaning validations, disinfectant efficacy studies, environmental monitoring, extractables and leachables testing, residuals testing, root cause investigation, spent media analysis, and water system validation.
• GMP Manufacturing Services Good Manufacturing Practice compliant manufacturing services including fill and finish, batch release with QC and QP support, labelling and packaging, and supporting services for small-scale compounding.
• Medical Devices Testing Services Complete testing services for medical devices covering biocompatibility, chemical characterization, chemical and physical analysis, microbiology and sterility, packaging and seal integrity testing, packaging and sterilisation, reprocessing cleaning validations, and shelf-life and product stability studies.
• Method Development and Validation Development of test methods from scratch or transfer of client methods under regulatory compliant conditions for drug substances, final products, intermediates, and starting materials.
• Release Testing Services Comprehensive release testing services including biosafety testing (endotoxin, molecular biology, mycoplasma, virology), container closure integrity testing, identity testing, import testing, oligonucleotide testing, potency testing, quality control testing, and solid-state characterization.
• Stability Testing Services Stability testing services to determine shelf life and storage conditions for small molecule pharmaceuticals, biologics, medical devices, and biocides.
• Small Molecules Testing Services Testing services for small molecule pharmaceutical products including drug substances, final products, intermediates, and starting materials with facility and process control, GMP manufacturing, method development, release testing, and stability testing.
• Biologics Testing Services Testing services for biological pharmaceutical products including cell banks, facility and process control, GMP manufacturing, method development, release testing, and stability testing for large molecule drug products.
• LabAccess Portal Real-time access portal for customers to view and manage their laboratory data, access test results, and track sample status online.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Intertek Pharmaceutical Services: Intertek offers pharmaceutical and medical device laboratory testing services covering release, stability, extractables/leachables, and biocompatibility. Comparable as a multi-accredited, globally distributed testing CRO competing for similar regulated testing work.
• Charles River Laboratories: Global CRO providing biopharma safety assessment, analytical testing, and manufacturing support. Comparable through its biopharma testing, release, and stability services for regulated drug products, though it operates at much broader scale across the drug development lifecycle.
• WuXi AppTec Laboratory Testing Division: WuXi provides bioanalytical, release, and stability testing services for biologics and small molecules, and competes for biopharma outsourcing spend. Differentiated by larger scale and integrated discovery-to-manufacturing platform but highly comparable in lab testing offerings.
• ICON plc (PRA Health / central labs): ICON operates central laboratory and bioanalytical services supporting clinical trials and biopharma testing. Comparable through its regulated lab testing, biomarker analysis, and central lab services for pharma clients, though anchored to clinical trial delivery.
• SGS Life Sciences: SGS provides laboratory testing services including pharmaceutical release testing, stability, microbiology, and medical device testing. A direct competitor in the same CRO laboratory services space with a comparable multi-geography, multi-accreditation profile.
• Labcorp / Covance Central Laboratory: Labcorp's central and specialty laboratories provide clinical and biopharma testing services including release testing, biomarker analysis, and stability work. Comparable as a regulated, accredited testing provider serving pharma and medical device manufacturers.

Direct peers

• Eurofins BioPharma Product Testing (other geographies): Sister entities within the Eurofins BioPharma Product Testing network offering the same release, stability, method development, and GMP services to biopharma and medical device clients across other geographies. Operate under the same parent and shared methodologies, making them the closest functional peers.
• Pace Analytical Life Sciences: Pace Life Sciences provides GMP/GLP pharmaceutical and medical device testing services including release, stability, and method development. A focused CRO competitor in the same niche as Proxy Laboratories with comparable accreditations and customer base.

Emerging players

• Catalent Pharma Solutions: Catalent provides small-scale GMP fill & finish, clinical supply services, and analytical testing that overlap with Proxy's GMP manufacturing and release testing offerings. Comparable specifically on the small-batch aseptic fill & finish capability for clinical and commercial supply.

Regional players

• Nemera / Recipharm analytical services: Recipharm (and similar European CDMOs) provides analytical services, stability, and release testing alongside manufacturing. Comparable as a European-headquartered CRO/CDMO offering integrated testing and small-scale GMP manufacturing to pharma clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/proxy-laboratories

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proxy Laboratories